ATOS
Atossa Genetics Inc
NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY
$5.37
+1.70% today
Updated 2026-04-30
Market cap
$49.09M
P/E ratio
—
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
—
52W range
$4 – $19
Volume
0.1M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$23.00
+328.31%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-10.55M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-26.23M | $-30.09M | $-25.50M | $-34.77M | $-10.94M |
| EPS | — | — | — | — | $-4.04 |
| Free cash flow | $-20.79M | $-20.95M | $-21.05M | $-29.79M | $-10.55M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Atossa Genetics Inc trades at $5.37. Our Smart Value Score of 25/100 indicates the stock is weak.
Frequently asked questions
What is Atossa Genetics Inc's stock price?
Atossa Genetics Inc (ATOS) trades at $5.37.
Is Atossa Genetics Inc overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Atossa Genetics Inc (ATOS)?
The analyst target price is $23.00, representing +328.3% upside from the current price of $5.37.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1,872.06x
ROE-62.70%
Beta1.35
50D MA$4.97
200D MA$10.01
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—